Pemetrexed Injection, Powder, Lyophilized, For Solution
NDC Package 72338-101-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Pemetrexed (pemetrexed disodium) injection is pemetrexed is used to treat certain types of cancer (such as lung cancer, mesothelioma). This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Waverley Pharma Inc, this product is identified by NDC 72338-101 and is authorized under FDA application ANDA211899.

Identification & Billing

NDC Package Code
72338-101-01
Package Description
1 VIAL in 1 CARTON / 20 mL in 1 VIAL
Product Code
72338-101
11-Digit Billing Format
72338010101
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Pemetrexed
Non-Proprietary Name
Pemetrexed Disodium
Substance Name
Pemetrexed Disodium Heptahydrate
Dosage Form
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
PEMETREXED DISODIUM HEPTAHYDRATE 500 mg/20mL
Pharmacologic Class
Usage Information
Pemetrexed is used to treat certain types of cancer (such as lung cancer, mesothelioma). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.

Regulatory & Marketing

Labeler Name
Waverley Pharma Inc
Product Type
Human Prescription Drug
FDA Application #
ANDA211899
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-04-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72338-101-01 identifies a specific commercial package of 1 vial in 1 carton / 20 ml in 1 vial of Pemetrexed, a human prescription drug labeled by Waverley Pharma Inc. This injection, powder, lyophilized, for solution is formulated for intravenous use and contains pemetrexed disodium heptahydrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Waverley Pharma Inc on June 04, 2018. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Pemetrexed is used to treat certain types of cancer (such as lung cancer, mesothelioma). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.

How is this Waverley Pharma Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72338010101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72338-101-01
11-Digit CMS (5-4-2)
72338-0101-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.